drugset / Trial / NCT00230568

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00230568

Phase 4 Completed 100 enrolled Eisai Inc. Pfizer · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.

Timeline

Start
2005-12
Primary completion
2007-04
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications